← FDA DRUG APPROVALS

FDA ANDA · ANDA203787

DESOXIMETASONE

Sponsor: SCIEGEN PHARMS

APPLICATION
ANDA203787
TYPE
ANDA
ORIGINAL APPROVAL
2017-01-06
LATEST ACTION
2026-03-16
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Prescription

Products

DESOXIMETASONEPrescription
DESOXIMETASONE 0.05% · CREAM · TOPICAL

Approval history

2026-03-16Manufacturing (CMC) · Supplement 2 · unknownAP
2017-01-06UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →